SPANISH LUNG CANCER GROUP

MESOTHELIOMA

PROMISE-Meso

Multicentre randomised phase III trial comparing pembrolizumab versus standard chemotherapy for advanced pre-treated malignant pleural mesothelioma.

Promotor: ETOP
Coordinador en España: Dr. Ernest Nadal

Centros participantes
  • Institut Català d’Oncologia-Hospitalet
  • Hospital Clínico Universitario de Valladolid
  • Hospital Teresa Herrera, A Coruña

Switch The Language

Award winning creative agency

We are building for tomorrow because tomorrow is the future and we want to make a contribution to the wonderful digital age that is awaiting us.